IMMR at the forefront of Connected MD preclinical development

IMMR Newsletter 24
The connected medical device market is booming, driven and drive down treatment costs. The estimated number of connected medical devices (devices connected to the In-ternet) is expected to increase from 10 billion to 50 billion over the next decade, according to the IBM Institute for Bu-siness Value, and all the major companies like IBM, Cisco, GE Healthcare or Philips are investing in this field.

IMMR is at the forefront of connected MD preclinical development, being highly experienced in the assessment of these emerging medical technologies. Indeed, connected healthcare solutions, such as heart failure connected MD, require precise, real-time and uninterrupted measurements and control. At IMMR, data collection is an automatic routine and we have all the capabilities to handle continuous health-care monitoring data flow regarding a specific pathology. We implement rigorous and strict comparisons of the collected data from a connected MD with the one collected from gold standard validated procedures. We have a state-of-the-art technical platform and all the latest generation tools to do so, and we include in our protocols all the required existing standards to ensure efficacy and safety.

Download the newsletter